Synapse - Works

Results (115781)

Clinical development of new drugs for adults and children with cancer in 2010-2020: Longitudinal study of investigational drugs

Meeting Abstract

Arfe, A.; Narang, C.; DuBois, S. G.; Reaman, G. H.; Bourgeois, F.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A phase 1/2 dose-escalation and dose-expansion study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma

Meeting Abstract

Avutu, V.; Slotkin, E. K.; Livingston, J. A. A.; Chawla, S. P.; Pressey, J. G.; Nandkumar, P.; Zheng, C.; Misir, S.; Pultar, P.; Voliotis, D.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Matching-adjusted indirect comparison (MAIC) of teclistamab (tec) versus selinexordexamethasone (sel-dex) for the treatment of patients (pts) with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Bahlis, N. J.; Usmani, S. Z.; Rosiñol, L.; Krishnan, A. Y.; Nooka, A. K.; Rocafiguera, A. O.; Delforge, M.; Garfall, A. L.; van De Donk, N. W. C. J.; Rodríguez-Otero, P.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma

Meeting Abstract

Balachandran, V. P.; Rojas, L. A.; Sethna, Z.; Soares, K.; Derhovanessian, E.; Mueller, F.; Yadav, M.; Basturk, O.; Gonen, M.; Wei, A. C. C.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Exploring perceptions of gender bias in oncology: A survey study

Meeting Abstract

Balanchivadze, N.; McKay, C.; Nasser, Z.; Passalacqua, K. D.; Li, P.; Chino, F.; Duma, N.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Safety and clinical activity of MEDI5752, a PD-1/CTLA-4 bispecific checkpoint inhibitor, as monotherapy in patients (pts) with advanced renal cell carcinoma (RCC): Preliminary results from an FTIH trial

Meeting Abstract

Albiges, L.; Rodriguez, L. M.; Kim, S. W.; Im, S. A.; Carcereny, E.; Rha, S. Y.; Tran, B.; Oliveira, J.; Maroto-Rey, P.; Su, W. C.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Dose-finding and -expansion studies of trastuzumab deruxtecan in combination with other anti-cancer agents in patients (pts) with advanced/metastatic HER2+ (DESTINY-Breast07 [DB-07]) and HER2-low (DESTINY-Breast08 [DB-08]) breast cancer (BC)

Meeting Abstract

Andre, F.; Hamilton, E. P.; Loi, S.; Im, S. A.; Sohn, J.; Tseng, L. M.; Anders, C. K.; Schmid, P.; Boston, S.; Darilay, A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

First-line brentuximab vedotin plus chemotherapy to improve overall survival in patients with stage III/IV classical Hodgkin lymphoma: An updated analysis of ECHELON-1

Meeting Abstract

Ansell, S. M.; Connors, J. M.; Radford, J. A.; Kim, W. S.; Gallamini, A.; Ramchandren, R.; Friedberg, J. W.; Advani, R. H.; Hutchings, M.; Evens, A. M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

ZENYTH-ESO: Master protocol to assess the safety and recommended phase II dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and myxoid/round cell liposarcoma [Substudy 3, GSK4427296]

Meeting Abstract

Araujo, D. M.; Ladle, B. H.; He, K.; Powers, B.; McGillivray, A.; Mitrica, I.; Liu, W.; Patel, N.; D'Angelo, S. P.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Subcutaneous epcoritamab + R-DHAX/C in patients (pts) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) eligible for autologous stem cell transplant (ASCT): Preliminary phase 1/2 results

Meeting Abstract

Abrisqueta, P.; Falchi, L.; Phillips, T. J.; De Vos, S.; Nijland, M.; Offner, F.; Bykhovski, I.; Wu, J.; Wang, L.; Rana, A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save